Načítá se...
Associations between metabolic syndrome, breast cancer recurrence, and the 21-gene recurrence score assay
PURPOSE: The 21-gene recurrence score (RS) assay is prognostic in estrogen receptor-positive (HR+), HER2 negative, node negative breast cancer (BC). The interaction between RS and host factors including metabolic syndrome (MS) is unclear. MS conditions such as obesity have been associated with worse...
Uloženo v:
| Vydáno v: | Breast Cancer Res Treat |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5095927/ https://ncbi.nlm.nih.gov/pubmed/27271766 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-016-3846-4 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|